Bill Snyder Archive — Page 116 of 120
-
October 11, 2012
VU scientists cheer Nobel Prize for stem cell research
Vanderbilt University scientists are cheering this year’s Nobel Prize in Medicine for recognizing the discovery that mature cells can be “reprogrammed” into other cell types — a finding which they said has electrified their work. -
October 11, 2012
VU recruit’s work lights up genetic ‘dark matter’
They’ve been called “junk DNA” and genetic “dark matter” — the long segments of the human genome (98 percent of it) that do not encode protein. -
September 27, 2012
Quantitative and Chemical Biology Program takes shape
The Chemical and Physical Biology Admissions (CPB-A) Program, an inter-departmental first-year graduate admissions program at Vanderbilt University, has been renamed the Quantitative and Chemical Biology (QCB) Program. -
September 27, 2012
VU Research Studio Program lauded at AAMC meeting
Vanderbilt University’s Clinical and Translational Research Studio program has won the Award with Distinction for Innovations in Research Training and Education from the Association of American Medical Colleges (AAMC). -
September 27, 2012
AAMC meet highlights need for research funds
During a meeting in Nashville last week, the director of the National Institutes of Health (NIH) called on academic medical centers to make the case for continued, strong federal investment in biomedical research. -
September 21, 2012
VU, Bristol-Myers to collaborate on Parkinson’s therapies
Vanderbilt University and Bristol-Myers Squibb have signed a collaboration agreement for the discovery, development and commercialization of novel therapies acting on the mGluR4 glutamate receptor, known as positive allosteric modulators, or PAMs, for the treatment of Parkinson’s disease.